Mercer Global Advisors Inc Galapagos Nv Transaction History

Mercer Global Advisors Inc

  • $45.6 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$96.85 - $148.25 $348,853 - $533,996
-3,602 Closed
0 $0
Q3 2020

Dec 10, 2020
BUY
$122.47 - $213.56 $51,927 - $90,549
424 Added 13.34%
3,602 $511,000
Q2 2020

Aug 10, 2020
BUY
$185.52 - $231.25 $589,582 - $734,912
3,178 New
3,178 $627,000

Others Institutions Holding GLPG

# of Institutions
84
Shares Held
12.3M
Call Options Held
69.1K
Put Options Held
42.7K
View Full List

About GALAPAGOS NV

GLPG Quotes by TradingView
  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.79B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email